- Report
- May 2024
- 139 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 135 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- March 2024
- 150 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Clinical Trials
- November 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Drug Pipelines
- March 2025
- 180 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- October 2024
- 160 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- August 2024
- 240 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more